CPAP machines typically cost between $500 and $3,000 out of pocket, and the price stays high because of a combination of regulatory requirements, a concentrated market with few manufacturers, built-in technology costs, and a healthcare billing system that has little incentive to push prices down. No single factor explains the price tag, but together they create a market where consumers have limited options and little negotiating power.
Only a Few Companies Control the Market
The CPAP market is dominated by just two major manufacturers: ResMed and Philips Respironics. A handful of smaller players exist, but these two companies account for the vast majority of devices sold worldwide. When an entire product category is controlled by two or three firms, there’s little competitive pressure to lower prices. Both companies can set premium price points knowing that patients need the device nightly and have few alternatives.
This concentration got even worse in 2021 when Philips recalled millions of its CPAP and BiPAP machines due to a degrading foam component. That recall effectively left ResMed as the dominant supplier for an extended period, tightening supply and removing what competitive pressure existed. Prices didn’t drop. If anything, the reduced supply made machines harder to find at any price.
FDA Regulation Adds Real Costs
CPAP machines are classified as Class II medical devices by the FDA, which means manufacturers must go through a formal clearance process before selling in the United States. The most common pathway, called a 510(k) submission, carries a user fee of over $26,000 per application (or about $6,500 for qualifying small businesses). That fee alone isn’t enormous for a large company, but it’s just the entry point.
Behind that submission sits months or years of engineering documentation, biocompatibility testing, electrical safety testing, and quality system audits. Every manufacturer must also pay an annual establishment registration fee of roughly $11,400 just to maintain their ability to sell devices in the U.S. These costs layer on top of each other, and they apply not just to the machine itself but to each new mask, humidifier, or accessory that requires its own clearance. Smaller companies face these same barriers, which helps explain why so few competitors enter the market.
Built-In Technology You’re Paying For
Modern CPAP machines are no longer simple air pumps. Most current models include auto-adjusting pressure algorithms that respond to your breathing patterns in real time, heated humidifiers, cellular wireless connectivity, and companion apps that track your sleep data. That cellular connection, which transmits your usage data to your doctor and insurance company each night, costs the manufacturer money. Companies like ResMed contract with cellular providers for bandwidth over the expected life of the machine and bake that cost into the purchase price.
The proprietary software running these devices represents significant research and development investment. Auto-titrating algorithms that detect apneas, hypopneas, and flow limitations require years of clinical validation. Manufacturers also maintain cloud platforms that store and process your nightly data. You’re not just buying a motor and a hose. You’re buying into a connected ecosystem, whether you want all of those features or not.
The Insurance System Doesn’t Drive Prices Down
In most consumer markets, high prices eventually attract competitors or push buyers toward cheaper options. Medical devices don’t work that way. Most CPAP machines in the U.S. are obtained through insurance or Medicare, and the billing process insulates both patients and manufacturers from normal price competition.
Medicare and many private insurers don’t purchase the machine outright for you. Instead, they use a rent-to-own model, paying a durable medical equipment (DME) supplier a monthly fee over 13 months. The total reimbursement often exceeds what you’d pay buying the machine directly online. DME suppliers have little reason to negotiate aggressively with manufacturers when the reimbursement rates are already set by Medicare fee schedules. And patients, shielded from the full price by copays, rarely shop around. The result is a system where nobody in the transaction is strongly motivated to find a lower price.
Buying a CPAP machine out of pocket online can actually be cheaper than going through insurance in some cases, but many patients don’t realize this, and you still need a prescription regardless of how you purchase.
Replacement Parts Add Up Fast
The sticker price of the machine is only part of the total cost. CPAP therapy requires regular replacement of consumable parts on a schedule that can feel aggressive. Industry guidelines recommend replacing nasal cushions or pillows every two weeks, full-face mask cushions monthly, tubing every three months, and the mask frame and headgear every six months.
Following that schedule strictly, you could easily spend $300 to $500 per year on supplies alone. Many users stretch these intervals longer than recommended, but the ongoing cost is real. Insurance typically covers replacements on a set schedule, though copays still apply. For uninsured patients, these recurring expenses can rival the cost of the machine itself over a few years. Manufacturers benefit from this model: selling a device that requires a steady stream of proprietary replacement parts creates reliable long-term revenue.
Prices Vary Significantly by Country
The same CPAP machine costs different amounts depending on where you buy it. In the UK, a ResMed AirMini sells for around £670 (roughly $850 USD), while older-generation machines can be found in the U.S. for $300 or less if you’re willing to buy a previous model. Prices in countries with centralized healthcare purchasing tend to be lower because a single government buyer can negotiate volume discounts that individual American consumers or small DME suppliers cannot.
Australia, where ResMed is headquartered, and several European countries also see lower retail prices for comparable machines. The difference isn’t primarily about manufacturing cost. It reflects the fragmented U.S. purchasing system, where thousands of small DME companies each buy relatively small quantities and pass costs along to insurers who reimburse at fixed rates. There’s no single large buyer applying downward pressure on the manufacturer’s pricing.
What Actually Costs Money to Build
The raw components inside a CPAP machine, a brushless motor, a pressure sensor, a small circuit board, a plastic housing, probably cost manufacturers well under $100 to assemble. The markup from manufacturing cost to retail price is substantial, even by medical device standards. But manufacturers point to the full picture: years of R&D for each new model, ongoing software development, regulatory compliance across dozens of countries, clinical studies, warranty service, and the cellular data infrastructure.
Whether those costs justify prices of $800 to $2,500 depends on your perspective. What’s clear is that the combination of regulatory barriers, market concentration, insurance system dynamics, and recurring supply costs creates a pricing structure that stays high even as the underlying technology becomes more standardized. Until more competitors enter the market or purchasing models change, CPAP prices are unlikely to drop significantly.